News

Pfizer has revealed it was rebuffed once again by AstraZeneca over the weekend about a potential takeover of the UK company, with the latter's shares soaring in early trading today in reaction.

The Financial Ombudsman Service (FOS) has rejected five out of 43 claims at decision stage against advice to invest in Arch Cru since it started publishing complaints decisions last April, its data has shown.

The rise in special dividends from groups including Vodafone has led to a record quarter for dividend payments, although dividend growth slowed excluding the telecom giant's bumper payout.

Standard Life Investments' head of global equities David Cumming has said the group has finally lost patience with banks over bonuses, prompting last week's shock decision to publicly oppose Barclays' remuneration plans.

An execution-only investment platform launched a year ago by Surrey-based IFA Informed Choice has closed to new business after its pricing terms became uncompetitive.

Law firm Regulatory Legal is preparing to launch a case against Baker Tilly over alleged mis-selling of Brandeaux property funds.

Venture Capital Trusts have been hoarding investor cash after an error from HM Revenue and Customs left the vehicles afraid of issuing new shares.

RBS could suffer a "material adverse effect" should Scots vote for independence in September this year, the Edinburgh-headquartered bank has warned.

Stephen Jones, chief investment officer of Kames Capital, has said the UK's improving GDP figures mean it is now rivalling some emerging markets in the growth stakes.

GAM has launched a tactical multi-asset fund to be run by its asset allocation team, headed by Graham Wainer.